By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TARGET Pharmasolutions 

994 Cleland Drive

Chapel Hill  North Carolina  27517  U.S.A.
Phone: 317-625-1380 Fax:


SEARCH JOBS

TARGET Pharmasolutions was formed in February 2015, based on the success of HCV-TARGET, a case study of the model in Hepatitis C. Formed in 2011 by Dr. Michael Fried (University of North Carolina) and Dr. David Nelson (University of Florida), there are over 10,000 patients enrolled at 58 sites worldwide. The FDA has entered into a Memo of Understanding with HCV-TARGET and is an active participant on the advisory committee directing the clinical analysis. Through the utilization of this data, one sponsor has expanded their label and others have mitigated costly Phase IV commitments.

YEAR FOUNDED:

2015

LEADERSHIP:

Co-Founder, CEO and President: Meg Powell, Pharm.D.

CFO: Karen J. Adams

Co-Founder and Scientific Advisor: Michael W. Fried, MD

Co-Founder and Scientific Advisor: David Nelson, MD

Director of Clinical Operations: Laura Malahias

Director of Clinical Operations: Shelby Gainer

Director of Data Management: Ken Bergquist

Director of Medical Affairs: Monika Vainorius, MD

VP Data Management and Statistical Reporting: George DeMuth


Key Statistics


Email: info@targetpharmasolutions.com
Ownership: Private

Web Site: TARGET Pharmasolutions
Employees:
Symbol: 
 



Industry
Services






Company News
//-->